Manufacturers report positive results for difelikefalin for pruritus in haemodialysis patients

In a phase III trial difelikefalin (a highly selective agonist of the κ-opioid receptor), there was a statistically significant improvement in Worst Itching Intensity numerical rating score vs. placebo (p=0.02).

Source:

Biospace Inc.